Yonsei University
Clinical trials sponsored by Yonsei University, explained in plain language.
-
Promising chemo combo targets rare sarcomas in new trial
Disease control Recruiting nowThis study tests a chemotherapy combination (pemetrexed and cisplatin) in people with advanced or recurrent soft tissue sarcoma that has not responded well to previous treatments. The goal is to see if this drug pair can slow or stop tumor growth. About 164 adults with specific s…
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated May 26, 2026 06:55 UTC
-
New combo aims to shrink kidney tumors in Second-Line treatment
Disease control Recruiting nowThis study tests whether adding the experimental drug SLC-3010 to the standard drug axitinib works better than axitinib alone for people with advanced clear cell kidney cancer that has worsened after first treatment. About 78 adults will be randomly assigned to one of the two gro…
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated May 26, 2026 06:54 UTC
-
Could raising blood pressure after stroke improve recovery?
Disease control Recruiting nowThis study looks at whether slightly raising blood pressure after a stroke clot removal procedure helps patients recover better than the usual approach. About 176 adults who had a stroke and whose blood pressure stays low after the procedure will be randomly assigned to either a …
Phase: PHASE3 • Sponsor: Yonsei University • Aim: Disease control
Last updated May 26, 2026 06:52 UTC
-
Immunotherapy combo shows promise against advanced lung cancer
Disease control Recruiting nowThis study tests adding the immunotherapy drug durvalumab to standard chemotherapy and radiation before surgery for people with stage III non-small cell lung cancer. The goal is to see if this combination is safe and can improve outcomes like tumor shrinkage and survival. Researc…
Phase: PHASE1, PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated May 26, 2026 06:51 UTC
-
New vaccine combo shows promise against tough head and neck cancer
Disease control Recruiting nowThis study tests a new combination therapy for people with advanced head and neck cancer caused by HPV. The treatment includes a DNA vaccine (GX-188E), an immune booster (GX-I7), and an immunotherapy drug (nivolumab). The goal is to see if this combination can shrink tumors and h…
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated May 26, 2026 06:51 UTC
-
New beam of hope: carbon ions target stubborn liver tumors
Disease control Recruiting nowThis study tests a precise type of radiation called carbon ion radiotherapy for people with liver cancer that still has active tumors after a prior treatment called TARE. The goal is to see if this approach can safely shrink or control those remaining tumors. About 48 adults with…
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated May 26, 2026 06:49 UTC
-
Could a diabetes pill stop AFib from returning after ablation?
Disease control Recruiting nowThis study is testing whether a drug called Enavogliflozin, currently used for diabetes, can help prevent atrial fibrillation (an irregular heartbeat) from coming back after a catheter ablation procedure in people who also have heart failure. About 390 adults aged 19 to 85 will b…
Phase: PHASE4 • Sponsor: Yonsei University • Aim: Disease control
Last updated May 26, 2026 06:48 UTC
-
New study tests best statin dose for Seniors' heart health
Disease control Recruiting nowThis study looks at whether low or moderate doses of statins work better and cause fewer muscle problems in healthy adults aged 70 and older who have high cholesterol or heart disease risk. About 724 participants will take either a low or moderate statin and be monitored for musc…
Phase: PHASE4 • Sponsor: Yonsei University • Aim: Disease control
Last updated May 26, 2026 06:46 UTC
-
New combo shrinks lung tumors before surgery in targeted therapy trial
Disease control Recruiting nowThis study tests a drug called lazertinib, given alone or with chemotherapy, before surgery for people with a specific type of lung cancer (EGFR-mutated non-small cell lung cancer). The goal is to see if the treatment shrinks the tumor enough to improve surgery results. About 160…
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated May 26, 2026 06:45 UTC
-
Can a phone app boost heart and brain health after ablation?
Disease control Recruiting nowThis study tests whether a smartphone app-based care plan helps people with atrial fibrillation (AFib) recover better after a heart ablation procedure called FARAPULSE. About 500 adults who are getting their first FARAPULSE treatment will be randomly assigned to standard care or …
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated May 26, 2026 06:45 UTC
-
Kidney Patients' heart stent recovery: shorter blood thinners may be safer?
Disease control Recruiting nowThis study looks at how long people with advanced chronic kidney disease should take two blood thinners (aspirin plus clopidogrel or prasugrel) after getting a heart stent. About 900 adults with severe kidney disease will be randomly assigned to either a short or long course of d…
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated May 26, 2026 06:45 UTC
-
New radiation beam offers hope for frail pancreatic cancer patients
Disease control Recruiting nowThis study tests a precise form of radiation called carbon ion radiotherapy in 33 frail adults with pancreatic cancer who cannot have surgery or standard chemotherapy. The goal is to see if this treatment can help control the tumor and improve survival with fewer side effects. Pa…
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated May 26, 2026 06:44 UTC
-
New pacing technique may cut heart failure risk in pacemaker users
Disease control Recruiting nowThis study tests if a newer pacing method, left bundle branch area pacing (LBBAP), is better than standard right ventricular pacing (RVP) for people who need a pacemaker most of the time. The goal is to see if LBBAP reduces the risk of death, heart failure, or heart muscle damage…
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New hope for rare gynecological cancer: immunotherapy combo tested against chemo
Disease control Recruiting nowThis study tests whether the immunotherapy drug dostarlimab, given alone or with bevacizumab, works better than standard chemotherapy for people with recurrent gynecological clear cell carcinoma (a rare cancer of the ovary, uterus, cervix, vagina, or vulva). About 198 participant…
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New stomach drug may improve blood thinner safety after heart stent
Disease control Recruiting nowThis study looks at whether a new acid-reducing medicine called zastaprazan works better than standard drugs (PPIs) at keeping blood thinners working properly in heart patients. About 100 adults with chronic heart disease who recently had a stent placed will take either zastapraz…
Phase: PHASE4 • Sponsor: Yonsei University • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New combo therapy aims to shrink liver tumors that standard drugs can't stop
Disease control Recruiting nowThis study is for people with advanced liver cancer that cannot be removed by surgery. It combines a precise type of radiation (carbon ion radiotherapy) with two standard drugs (atezolizumab and bevacizumab) to see if the radiation helps control the tumor better. About 52 adults …
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated May 20, 2026 12:08 UTC
-
Heart valve study: which blood thinner works best after TAVR?
Disease control Recruiting nowThis study looks at two common blood thinners, aspirin and clopidogrel, to see which one better prevents small blood clots on the new heart valve after a TAVR procedure. About 254 people with severe aortic stenosis will take both drugs for 4 weeks after surgery, then switch to ju…
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New hope for ovarian cancer: targeted drug takes on resistant tumors
Disease control Recruiting nowThis study tests a new drug, trastuzumab deruxtecan (T-DXd), in people with recurrent ovarian cancer whose tumors have stopped responding to PARP inhibitors. T-DXd targets a protein called HER2 found on some cancer cells. The trial compares T-DXd to standard chemotherapy to see w…
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
Immunotherapy drug may boost outcomes for advanced nasopharyngeal cancer patients
Disease control Recruiting nowThis study tests whether the immunotherapy drug nivolumab can help people with advanced nasopharyngeal cancer who still have signs of cancer after standard chemotherapy and radiation. About 57 adults aged 19 and older will receive nivolumab infusions. The main goal is to see if t…
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated May 18, 2026 12:01 UTC
-
Robots take on breast cancer: a new era in surgery?
Disease control Recruiting nowThis study compares robot-assisted nipple-sparing mastectomy to the traditional open surgery for women with early-stage breast cancer (stage 0 to IIIa) who want immediate breast reconstruction. About 790 participants will be randomly assigned to one of the two surgical methods. T…
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Heart patients may get extra protection from cholesterol combo therapy
Disease control Recruiting nowThis study compares two treatments for people who have had a heart stent placed: a high-intensity statin alone versus the same statin plus ezetimibe. The goal is to see if the combination therapy better prevents death, heart attacks, strokes, or the need for additional procedures…
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated May 06, 2026 16:03 UTC
-
New ultrasound trick could replace costly scans for liver hemangiomas
Diagnosis Recruiting nowThis study tests a new ultrasound technique called Fluctuational Imaging (FLI) to see if it can accurately diagnose hepatic hemangiomas, the most common benign liver tumor. Currently, many patients need contrast CT or MRI for a clear diagnosis, which adds cost and radiation. The …
Sponsor: Yonsei University • Aim: Diagnosis
Last updated May 26, 2026 06:56 UTC
-
Exercise study aims to boost fitness in rare lung infection patients
Symptom relief Recruiting nowThis study tests whether a 6-week exercise program can improve exercise capacity and quality of life in people with nontuberculous mycobacterial pulmonary disease (NTM-PD), a chronic lung infection. Researchers will enroll 50 adults aged 40-80 and randomly assign them to start ex…
Phase: NA • Sponsor: Yonsei University • Aim: Symptom relief
Last updated May 26, 2026 06:58 UTC
-
New wire technique may boost blood flow and healing in legs at risk
Symptom relief Recruiting nowThis study compares two methods to guide balloon treatment for blocked leg arteries in people with chronic limb-threatening ischemia (severe wounds). One method uses standard X-ray images; the other adds a pressure wire to measure blood flow. The goal is to see which approach bet…
Phase: NA • Sponsor: Yonsei University • Aim: Symptom relief
Last updated May 26, 2026 06:57 UTC
-
Chatbot coach: new app aims to curb heavy drinking
Symptom relief Recruiting nowThis study tests whether a friendly chatbot app can help high-risk drinkers cut back on alcohol. About 220 adults who want to drink less will use the app for 4 weeks, and researchers will check their drinking habits after 16 weeks. The goal is to see if the app's motivational con…
Phase: NA • Sponsor: Yonsei University • Aim: Symptom relief
Last updated May 22, 2026 13:54 UTC
-
New study aims to shield breast cancer patients from chemo side effect
Symptom relief Recruiting nowThis study tests whether a medicine called pegfilgrastim can prevent a dangerous drop in white blood cells (febrile neutropenia) in women with triple-negative breast cancer who are receiving a specific chemotherapy regimen. About 40 adult patients will receive pegfilgrastim after…
Phase: NA • Sponsor: Yonsei University • Aim: Symptom relief
Last updated May 22, 2026 13:53 UTC
-
Rare cancer patients wanted for landmark registry study
Knowledge-focused Recruiting nowThis study is creating a registry of 500 adults with rare cancers in Korea. Researchers will track how many patients go on to join clinical trials. No treatment or experimental drug is given—the goal is simply to collect information and improve future research.
Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated May 26, 2026 06:49 UTC
-
Heart scans reveal Drug's hidden impact on rare disease
Knowledge-focused Recruiting nowThis study looks at 25 people with Fabry disease, a rare genetic condition that can damage the heart. Participants will take a drug called agalsidase alfa for 12 months. Researchers will use special heart scans (PET-CMR) at the start and after one year to see if the drug reduces …
Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated May 26, 2026 06:49 UTC
-
Heart roadmap may speed up artery checks
Knowledge-focused Recruiting nowThis study looks at whether a special map called a dynamic coronary roadmap can help doctors perform heart artery pressure tests more quickly. About 226 adults with narrowed heart arteries will be randomly assigned to get the map or not during their procedure. The main goal is to…
Phase: NA • Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC
-
Robot hip helper: scientists test exoskeleton on walkers
Knowledge-focused Recruiting nowThis study looks at how a wearable robotic hip device affects the way healthy adults walk. Researchers will measure step length, speed, muscle activity, and foot pressure under different levels of assistance from the exoskeleton. The goal is to understand how the device changes n…
Phase: NA • Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated May 19, 2026 11:49 UTC
-
AI and smart insoles aim to forecast knee surgery success
Knowledge-focused Recruiting nowThis study looks at whether special insoles that measure how you walk, along with other health information, can predict how much your knee will improve after replacement surgery. About 200 adults with knee osteoarthritis scheduled for surgery will participate. The goal is to help…
Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC
-
AI avatars vs. slides: which video calms cancer patients better?
Knowledge-focused Recruiting nowThis study compares two types of educational videos for people about to start radiation therapy: one made with an AI avatar and another using standard slides with voiceover. About 136 patients will watch one of the videos and answer questions about their anxiety and understanding…
Phase: NA • Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC